Concepedia

Author

Matti Davis

Hebrew University of Jerusalem

Also Known As

Matti Davis

12

Publications

1.2K

Citations

8

H-Index

26

Concepts

All Affiliations

Hebrew University of JerusalemBrigham and Women's Hospital
MD

About

Matti Davis is an author at Hebrew University of Jerusalem specializing in medicine, tumor biology, and molecular oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

947

2

Cell Biology

2

2

271

3

Engineering

1

1

17

4

Immunology

1

1

655

5

Molecular Medicine

1

1

17

Matti Davis

×

7

Publications

1.1K

Citations

7

H-Index

YearCitations

Identification of the receptor component of the IκBα–ubiquitin ligase

Avraham Yaron, Ada Hatzubai, Matti Davis,

Nature

1998

655

The Mammalian Cos2 Homolog Kif7 Plays an Essential Role in Modulating Hh Signal Transduction during Development

Setsu Endoh‐Yamagami, Marie Evangelista, Deanna G. Wilson,

Current Biology

2009

254

Pseudosubstrate regulation of the SCF <sup>β-TrCP</sup> ubiquitin ligase by hnRNP-U

Matti Davis, Ada Hatzubai, Jens Andersen,

Genes & Development

2002

119

Spermatogenesis rescue in a mouse deficient for the ubiquitin ligase SCF<sup>β-TrCP</sup> by single substrate depletion

Naama Kanarek, E. Philip Horwitz, Inbal Mayan,

Genes & Development

2010

39

AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling

Renata Ferrarotto, Vasudha Mishra, Elad Herz,

Cell Death and Disease

2022

39

A phase I study of AL101, a pan-NOTCH inhibitor, in patients (pts) with locally advanced or metastatic solid tumors.

Anthony B. El-Khoueiry, Jayesh Desai, Swaminathan P. Iyer,

Journal of Clinical Oncology

2018

21

AL101 mediated tumor inhibition in notch-altered TNBC PDX models.

Esther Channah Broner, Genia Alpert, Udi Gluschnaider,

Journal of Clinical Oncology

2019

17

Page 1